These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7223121)

  • 1. Activation of human complement by Yersinia enterocolitica: ultrastructural alterations and C3b-deposition.
    Acker G; Brade V
    Zentralbl Bakteriol A; 1980 Nov; 248(2):210-28. PubMed ID: 7223121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the alternative complement pathway by isolated human glomerular basement membrane.
    Williams JD; Czop JK; Abrahamson DR; Davies M; Austen KF
    J Immunol; 1984 Jul; 133(1):394-9. PubMed ID: 6373930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
    Clas F; Loos M
    Immunology; 1980 Aug; 40(4):547-56. PubMed ID: 6776034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fixation of C3b to pneumococcal cell wall polymers as a result of activation of the alternative complement pathway.
    Hummell DS; Berninger RW; Tomasz A; Winkelstein JA
    J Immunol; 1981 Oct; 127(4):1287-9. PubMed ID: 7024404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL; Mikus LK
    J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Giardia lamblia trophozoites to the lethal effect of human serum.
    Hill DR; Burge JJ; Pearson RD
    J Immunol; 1984 Apr; 132(4):2046-52. PubMed ID: 6699407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis.
    Ben Nasr A; Klimpel GR
    J Leukoc Biol; 2008 Jul; 84(1):77-85. PubMed ID: 18430786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway.
    Mann J; O'Brien R; Hostetter MK; Alper CA; Rosen FS; Babior BM
    J Immunol; 1981 Jun; 126(6):2370-2. PubMed ID: 6785350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb.
    Leijh PC; van den Barselaar MT; Daha MR; van Furth R
    J Immunol; 1982 Jul; 129(1):332-7. PubMed ID: 6979568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evasion of Yersinia enterocolitica serotype 03 from complement-mediated killing.
    Pilz D; Wachter E; Heesemann J; Brade V
    Behring Inst Mitt; 1991 Feb; (88):183-93. PubMed ID: 2049037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the activity of the alternative pathway of complement in BALB/c and C57Bl/6 mice.
    Ogunremi O; Tabel H; Kremmer E; Wasiliu M
    Exp Clin Immunogenet; 1993; 10(1):31-7. PubMed ID: 8398200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interactions between complement system and bacterial walls].
    Colomb MG; Bensa JC; Chesne S; Aubert B
    Bull Eur Physiopathol Respir; 1983; 19(2):131-6. PubMed ID: 6871492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lambda prophage decreases Escherichia coli sensitivity to human serum bactericidal effect.
    Vaca-Pacheco S; Piedra-Ibarra E; Arenas-Aranda D; Paniagua-Contreras GL
    Rev Latinoam Microbiol; 1993; 35(1):71-5. PubMed ID: 8140334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of bactericidal action of normal human serum against Salmonella rods.
    Mokracka-Latajka G; Jankowski S; Grzybek-Hryncewicz K; Krzyzanowska B
    Acta Microbiol Pol; 1996; 45(2):169-80. PubMed ID: 8997694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-independent killing of gram-negative bacteria via the classical pathway.
    Clas F; Loos M
    Behring Inst Mitt; 1984 Nov; (76):59-74. PubMed ID: 6525148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement consumption by Photobacterium damselae subsp. piscicida in seabream, red porgy and seabass normal and immune serum. Effect of the capsule on the bactericidal effect.
    Acosta F; Ellis AE; Vivas J; Padilla D; Acosta B; Déniz S; Bravo J; Real F
    Fish Shellfish Immunol; 2006 May; 20(5):709-17. PubMed ID: 16263309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of YadA, Ail, and Lipopolysaccharide in Serum Resistance of Yersinia enterocolitica Serotype O:3.
    Biedzka-Sarek M; Venho R; Skurnik M
    Infect Immun; 2005 Apr; 73(4):2232-44. PubMed ID: 15784567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.
    Krettli AU; Pontes de Carvalho LC
    Clin Exp Immunol; 1985 Nov; 62(2):270-7. PubMed ID: 3910312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.